As we were the first to report on Tuesday morning, the Biden administration has proposed major changes to the 340B program administrative dispute resolution process, including stripping the Centers for Medicare & Medicaid Services and the Department of
…
Groups that represent 340B covered entities said they looked forward to studying the federal government’s proposal Tuesday to revamp the 340B administrative dispute process, while the brand drug industry said it is still reviewing the proposal and that 340B remains “plagued
…
SPONSORED CONTENT
340B providers are facing an unprecedented number of challenges. 340B program managers are forced to react to these changes every day. Having access to clear and understandable data and developing strong relationships with partners in the 340B supply chain are critical to running an effective program. 340B leaders should consider the individual pieces of each 340B program, what
…
Separating the 340B drug discount program into one for hospitals and another for non-hospital healthcare providers would be the wrong response to drug company denials of 340B pricing when providers use contract pharmacies, AIDS Healthcare Foundation said yesterday.
…
A Richmond, Va., citizen’s group is continuing the fight against a health system accused of 340B program misuse at a hospital in a low-income, majority Black neighborhood in the wake of the death of U.S. Rep. A. Donald
…
The U.S. Department of Health and Human Services (HHS) said last week it would apply $350 million in unused monies from the COVID-19 Provider Relief Fund to launch a new initiative aimed at increasing COVID-19 vaccinations in underserved
…
Q: Where did you grow up?
I was born in Upstate New York and grew up in New Jersey.
Q: Where did you go to college/graduate school?
Fairleigh Dickinson
…
The U.S. Health Resources and Services Administration this morning proposed a replacement for its two-year-old 340B administrative dispute resolution process. Comments are due Jan. 30.
The U.S. Food and Drug Administration (FDA) last week approved the first gene therapy to treat adults with hemophilia B, a genetic bleeding disorder resulting from missing or insufficient levels of a protein needed to make blood clot.
…
SPONSORED CONTENT
Let’s get this right out on the table: At Avita, we believe health care is a human right.
Polarizing politics aside, as an advanced, civilized society, we have an ethical obligation to care for the medical needs of every U.S. citizen compassionately and equitably, regardless of their race, gender, sexual identity, or ability to
…*Sign up for news summaries and alerts from 340B Report
